"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

NCT04317248 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Cyclophosphamide
BIOLOGICAL: Multiple Signals loaded Dendritic Cells Vaccine

Sponsor

Yuehua Huang

Collaborators

[object Object]
[object Object]